Partner
Current• Represents leading pharmaceutical companies in Hatch-Waxman Act patent litigations and licensing negotiations:- Represented sole ANDA filer in litigation over combination antiretroviral product.- Represented ANDA filer in litigation over P2Y12 inhibitor.- Represented ANDA filer in litigation over lyophilized injectable hormone formulation.- Represented ANDA filer in litigation over injectable hormone depot formulation and in petitioning for inter partes review of the patents asserted in litigation.- Represented ANDA filer in litigation over atypical antipsychotic.• Represents leading technology companies in patent litigations and licensing negotiations involving diverse technologies:• Represented Ireland’s largest software company in a multi-patent bet-the-company lawsuit in the Eastern District of Virginia.• Represented a GPS-manufacturer in defending against a $60 million willful infringement claim. Non-infringement judgment affirmed by the Federal Circuit.• Represents defense contractor in litigation with the United States Air Force over rights in technical data under DoD contracts in case presenting important interpretive question of first impression.• Represents defense contractor in ongoing multi-million dollar litigation over a terminated Foreign Military Sales transaction.• Represents domain name owner in litigation over ownership of domain names before the Fifth Circuit.• Represented industry group before the Copyright Royalty Board to set digital sound recording performance fees for Internet streaming for 2016-2020.• Represented trademark applicants in appeals before the Trademark Trial and Appeal Board.• Successfully obtained reversal of adverse agency decision on behalf of a family of asylum seekers. Both v. Sessions, 705 F. App’x 609, 610 (9th Cir. 2017).• Represents a service member in litigation before the Court of Federal Claims to obtain wrongfully withheld military deployment pay.
